Drug Discovery and Development Strategies for COVID-19

Authors

  • Aarajana Shrestha College of Pharmacy, Yeungnam University, Gyeongsan 38541, Republic of Korea
  • Tara Man Kadayat Research Scientist, New Drug Development Center, Daegu-Gyeongbuk Medical Innovation Foundation, Daegu 41061, Republic of Korea

Keywords:

COVID-19, Drug Discovery and Development, Repurposed Drug

Abstract

Coronavirus Disease 2019 (COVID-19) has emerged as a global threat. Scientists and clinicians are endeavoring to find effective drugs and vaccines for this disease. This special issue of the Europasian Journal of Medical Sciences (EJMS) aims to cover the problems, solutions, and challenges of COVID-19 around the world. In this Editorial, EJMS Editors Aarajana Shrestha and Tara Man Kadayat highlight the processes of drug discovery and development and a brief overview of the current drug development strategies against COVID-19.

Downloads

Download data is not yet available.
Abstract
57
Download Full Text PDF
55

Author Biography

Aarajana Shrestha, College of Pharmacy, Yeungnam University, Gyeongsan 38541, Republic of Korea

Drug Discovery Researcher, Institute for Drug Research, Postdoctoral Research Program

Cover EJMS

Downloads

Published

2020-06-10

How to Cite

Shrestha, A., & Kadayat, T. M. (2020). Drug Discovery and Development Strategies for COVID-19. Europasian Journal of Medical Sciences, 2(2), 1–5. Retrieved from https://nepjol.info/index.php/ejms/article/view/33752

Issue

Vol. 2 No. 2 (2020): EJMS | COVID-19 Special Issue

Section

Editorial

License

Copyright (c) 2020 Author

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

All articles published in EJMS are licensed under the Creative Commons Attribution 4.0 International License (CC-BY 4.0). The author(s) as the copyright holder will retain the ownership of the copyrights without any restrictions for their content under the CC-BY 4.0 license, and allow others to copy, use, print, share, modify, and distribute the content of the article even in commercial purpose as long as the original authors and the journal are properly cited. No permission is required from the author/s or the publishers. Appropriate attribution can be provided by simply citing the original article.

On behalf of all the authors, the corresponding author is responsible for completing and returning the agreement form to the editorial office. More information about the terms and conditions, privacy policies, and copyrights can be found on the webpage of the Creative Commons license privacy policy. https://creativecommons.org/licenses/by/4.0/